Stefan Lehner
12Patents
3h-index
8Co-inventors
49Inventor score
Filing activity: Nov 5, 2007 → Apr 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8871795B2 | Pharmaceutical oral telmisartan solution | Human Necessities | 6 | Active |
| US8741350B2 | Taste masked pharmaceutical composition | Human Necessities | 5 | Active |
| US9289390B2 | Taste masked pharmaceutical composition | Human Necessities | 3 | Active |
| US9107952B2 | Liquid preparation comprising pimobendan | Performing Operations; Transporting | 2 | Active |
| US9795568B2 | Low concentration meloxicam tablets | Human Necessities | 1 | Active |
| US9943486B2 | Low concentration meloxicam tablets | Human Necessities | 1 | Active |
| US9616134B2 | Liquid preparation comprising pimobendan | Performing Operations; Transporting | 1 | Active |
| US10314782B2 | Oral suspension comprising telmisartan | Human Necessities | 1 | Active |
| US10639305B2 | Liquid preparation comprising pimobendan | Performing Operations; Transporting | 1 | Active |
| US10278924B2 | Low concentration meloxicam tablets | Human Necessities | 0 | Active |
| US10537523B2 | Oral suspension comprising telmisartan | Human Necessities | 0 | Active |
| US10905676B2 | Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.